<html><body>
<h1>Case: OneDrug_MF_anaphylaxisPio_818</h1>
65.0 year old White Male
<p><b>Numeric Data Values:</b></p>
<table>
<tr><td width="200">Diabetes Testing</td><td width="200"></td><td width="200"><td></tr>
<tr><td width="200">&nbsp;&nbsp;&nbsp;&nbsp;<b>HbA1C</b></td><td width="200">10.0</td><td width="200">2013-6-11</td></tr>
<tr><td width="200">&nbsp;&nbsp;&nbsp;&nbsp;Glycosylated_Hemoglobin</td><td width="200"></td><td width="200"><td></tr>
<tr><td width="200">&nbsp;&nbsp;&nbsp;&nbsp;PPG</td><td width="200"></td><td width="200"><td></tr>
<tr><td width="200">Blood Chemistry</td><td width="200"></td><td width="200"><td></tr>
<tr><td width="200">&nbsp;&nbsp;&nbsp;Chem7</td><td width="200"></td><td width="200"><td></tr>
<tr><td width="200">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Sodium</td><td width="200"></td><td width="200"><td></tr>
<tr><td width="200">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Potassium</td><td width="200"></td><td width="200"><td></tr>
<tr><td width="200">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Chloride</td><td width="200"></td><td width="200"><td></tr>
<tr><td width="200">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b>Bicarbonate</b></td><td width="200">25</td><td width="200">2013-6-11</td></tr>
<tr><td width="200">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;BUN</td><td width="200"></td><td width="200"><td></tr>
<tr><td width="200">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b>Creatinine</b></td><td width="200">1.50</td><td width="200">2013-6-11</td></tr>
<tr><td width="200">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b>eGFR</b></td><td width="200">55.0</td><td width="200">2013-6-11</td></tr>
<tr><td width="200">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Glucose</td><td width="200"></td><td width="200"><td></tr>
<tr><td width="200">&nbsp;&nbsp;&nbsp;Lipid Panel</td><td width="200"></td><td width="200"><td></tr>
<tr><td width="200">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total_Cholesterol</td><td width="200"></td><td width="200"><td></tr>
<tr><td width="200">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;HDL_Cholesterol</td><td width="200"></td><td width="200"><td></tr>
<tr><td width="200">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;LDL_Cholesterol</td><td width="200"></td><td width="200"><td></tr>
<tr><td width="200">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Calculated_LDL</td><td width="200"></td><td width="200"><td></tr>
<tr><td width="200">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Direct_Measure_LDL</td><td width="200"></td><td width="200"><td></tr>
<tr><td width="200">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Triglycerides</td><td width="200"></td><td width="200"><td></tr>
<tr><td width="200">&nbsp;&nbsp;&nbsp;&nbsp;Liver panel</td><td width="200"></td><td width="200"><td></tr>
<tr><td width="200">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Albumin</td><td width="200"></td><td width="200"><td></tr>
<tr><td width="200">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Alkaline_phosphatase</td><td width="200"></td><td width="200"><td></tr>
<tr><td width="200">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b>AST</b></td><td width="200">50.0</td><td width="200">2013-6-11</td></tr>
<tr><td width="200">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b>ALT</b></td><td width="200">50.0</td><td width="200">2013-6-11</td></tr>
<tr><td width="200">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total_Bilirubin</td><td width="200"></td><td width="200"><td></tr>
<tr><td width="200">&nbsp;&nbsp;&nbsp;&nbsp;Chemistry panel misc</td><td width="200"></td><td width="200"><td></tr>
<tr><td width="200">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Calcium</td><td width="200"></td><td width="200"><td></tr>
<tr><td width="200">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Creatine_Phosphokinase_CPK_or_CK</td><td width="200"></td><td width="200"><td></tr>
<tr><td width="200">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Phosphorus</td><td width="200"></td><td width="200"><td></tr>
<tr><td width="200">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Uric_Acid</td><td width="200"></td><td width="200"><td></tr>
<tr><td width="200">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;B 12</td><td width="200"></td><td width="200"><td></tr>
<tr><td width="200">Urine chemistry</td><td width="200"></td><td width="200"><td></tr>
<tr><td width="200">&nbsp;&nbsp;&nbsp;&nbsp;Creatinine_Clearance</td><td width="200"></td><td width="200"><td></tr>
<tr><td width="200">&nbsp;&nbsp;&nbsp;&nbsp;Microalbumin</td><td width="200"></td><td width="200"><td></tr>
<tr><td width="200">CHF tests</td><td width="200"></td><td width="200"><td></tr>
<tr><td width="200">&nbsp;&nbsp;&nbsp;&nbsp;BNP</td><td width="200"></td><td width="200"><td></tr>
<tr><td width="200">&nbsp;&nbsp;&nbsp;&nbsp;NT_proBNP</td><td width="200"></td><td width="200"><td></tr>
<tr><td width="200">Hematology</td><td width="200"></td><td width="200"><td></tr>
<tr><td width="200">&nbsp;&nbsp;&nbsp;&nbsp;AGN</td><td width="200"></td><td width="200"><td></tr>
<tr><td width="200">&nbsp;&nbsp;&nbsp;&nbsp;CBC</td><td width="200"></td><td width="200"><td></tr>
<tr><td width="200">&nbsp;&nbsp;&nbsp;&nbsp;HCT</td><td width="200"></td><td width="200"><td></tr>
<tr><td width="200">&nbsp;&nbsp;&nbsp;&nbsp;HGB</td><td width="200"></td><td width="200"><td></tr>
<tr><td width="200">&nbsp;&nbsp;&nbsp;&nbsp;PLT</td><td width="200"></td><td width="200"><td></tr>
<tr><td width="200">&nbsp;&nbsp;&nbsp;&nbsp;WBC</td><td width="200"></td><td width="200"><td></tr>
<tr><td width="200">Microbiology_Tests</td><td width="200"></td><td width="200"><td></tr>
<tr><td width="200">&nbsp;&nbsp;&nbsp;&nbsp;Hepatitis_B_Surface_Antigen</td><td width="200"></td><td width="200"><td></tr>
<tr><td width="200">&nbsp;&nbsp;&nbsp;&nbsp;Hepatitis_C_Status</td><td width="200"></td><td width="200"><td></tr>
<tr><td width="200">&nbsp;&nbsp;&nbsp;&nbsp;HIV_Test</td><td width="200"></td><td width="200"><td></tr>
<tr><td width="200">Pulmonary_Function_Studies</td><td width="200"></td><td width="200"><td></tr>
<tr><td width="200">&nbsp;&nbsp;&nbsp;&nbsp;DCL</td><td width="200"></td><td width="200"><td></tr>
<tr><td width="200">&nbsp;&nbsp;&nbsp;&nbsp;DLCO</td><td width="200"></td><td width="200"><td></tr>
<tr><td width="200">&nbsp;&nbsp;&nbsp;&nbsp;FEV1</td><td width="200"></td><td width="200"><td></tr>
<tr><td width="200">&nbsp;&nbsp;&nbsp;&nbsp;FVC</td><td width="200"></td><td width="200"><td></tr>
<tr><td width="200">respiratory gas exchange</td><td width="200"></td><td width="200"><td></tr>
<tr><td width="200">target_HBA1c</td><td width="200"></td><td width="200"><td></tr>
<tr><td width="200">Urinalysis</td><td width="200"></td><td width="200"><td></tr>
<tr><td width="200">&nbsp;&nbsp;&nbsp;&nbsp;Urine_Alb/creat_Ratio_24h</td><td width="200"></td><td width="200"><td></tr>
<tr><td width="200">&nbsp;&nbsp;&nbsp;&nbsp;Urine_ALB/CREAT_RATIO_spot</td><td width="200"></td><td width="200"><td></tr>
<tr><td width="200">&nbsp;&nbsp;&nbsp;&nbsp;UrineAlbumin_24H</td><td width="200"></td><td width="200"><td></tr>
<tr><td width="200">&nbsp;&nbsp;&nbsp;&nbsp;UrineAlbumin_SPOT</td><td width="200"></td><td width="200"><td></tr>
<tr><td width="200">&nbsp;&nbsp;&nbsp;&nbsp;UrineProtein_12h</td><td width="200"></td><td width="200"><td></tr>
<tr><td width="200">&nbsp;&nbsp;&nbsp;&nbsp;UrineProtein_24h</td><td width="200"></td><td width="200"><td></tr>
<tr><td width="200">&nbsp;&nbsp;&nbsp;&nbsp;UrineProtein_Qualitative</td><td width="200"></td><td width="200"><td></tr>
<tr><td width="200">&nbsp;&nbsp;&nbsp;&nbsp;UrineProtein_Spot</td><td width="200"></td><td width="200"><td></tr>
<tr><td width="200">Vital_Signs</td><td width="200"></td><td width="200"><td></tr>
<tr><td width="200">&nbsp;&nbsp;&nbsp;&nbsp;<b>Diastolic_BP</b></td><td width="200">79</td><td width="200">2013-6-11</td></tr>
<tr><td width="200">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Treatment_Diastolic_BP</td><td width="200"></td><td width="200"><td></tr>
<tr><td width="200">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;DB_Diastolic_BP</td><td width="200"></td><td width="200"><td></tr>
<tr><td width="200">&nbsp;&nbsp;&nbsp;&nbsp;<b>Systolic_BP</b></td><td width="200">120</td><td width="200">2013-6-11</td></tr>
<tr><td width="200">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Treatment_Systolic_BP</td><td width="200"></td><td width="200"><td></tr>
<tr><td width="200">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;DB_Systolic_BP</td><td width="200"></td><td width="200"><td></tr>
<tr><td width="200">&nbsp;&nbsp;&nbsp;&nbsp;BMI</td><td width="200"></td><td width="200"><td></tr>
<tr><td width="200">&nbsp;&nbsp;&nbsp;&nbsp;Height</td><td width="200"></td><td width="200"><td></tr>
<tr><td width="200">&nbsp;&nbsp;&nbsp;&nbsp;High_Cardiovascular_Risk</td><td width="200"></td><td width="200"><td></tr>
<tr><td width="200">&nbsp;&nbsp;&nbsp;&nbsp;Metabolic_Syndrome</td><td width="200"></td><td width="200"><td></tr>
<tr><td width="200">&nbsp;&nbsp;&nbsp;&nbsp;Pulse</td><td width="200"></td><td width="200"><td></tr>
<tr><td width="200">&nbsp;&nbsp;&nbsp;&nbsp;Weight</td><td width="200"></td><td width="200"><td></tr>
<tr><td width="200"><p>Others:</td></tr>
<tr><td width="200">&nbsp;&nbsp;&nbsp;&nbsp;<b>Age</b></td><td width="200">65</td><td width="200">1970-1-1</td></tr>
</table>
<p><b>Medications:</b> METFORMIN(2500.0[2013-02-27,  ]) lisinopril(0.0[  ,  ]{91.0, 2013-02-27}) 
<p><b>Qualitative Data:</b> </p><table>
<tr><td width="200">CVD DM</td><td width="200"></td><td width="200">2013-2-2</td></tr>
<tr><td width="200">Diabetes Type 2</td><td width="200"></td><td width="200">2013-2-27</td></tr>
<tr><td width="200">Race</td><td width="200">White</td><td width="200"></td></tr>
<tr><td width="200">Session Date</td><td width="200">2013-07-3</td><td width="200">2013-7-3</td></tr>
<tr><td width="200">Sex</td><td width="200">Male</td><td width="200"></td></tr>
</table><p>
<p><b>Allergies and Adverse Reactions:</b> <ul>
<li>Substance: PIOGLITAZONE Reaction: Anaphylaxis
 </ul>
<h2 align="center">ATHENA DM:  Glycemic Control Dashboard</h2>
<p><b> KB loaded from /Users/tu/Documents/Dropbox/VA/ATHENA/athenakbs/ATHENA_DM_GlycemicControl_Dashboard.pprj</b>(last modified: 05/31/2018)</p><p></p>
<b>Patient classification:</b> <ul>
<li>ATHENA DM:  Glycemic Control Dashboard: true[because <i> Eligibility criteria </i> evaluate to <b>true</b><i>(Age(65.0:01/01/1970) && NOT (Pres of DM-1 and Abs of DM-2) && Age(65.0:01/01/1970))</i>]
</ul>
<b>Scenario choice:</b> Scenario on One or Two encoded drugs not insulin
<p>
<b>Goal:</b> HbA1c <= 9%(Presence of HbA1c)
<p><b>Reached goal?</b> failed(HbA1c(10.0:06/11/2013))
<p><b>Action Choices</b>
<ul>
<li><b>dAll CDS scenarios No ACE/ARB</b><br>
<ul>
<li><b>Metformin checks <font color=FF0000>preferred</font></b>(rule in criterion<i> Pres biguanide and not biguanide contraindicated</i> evaluate to <b> true</b> because <i>not biguanide contraindicated</i>)])
<ul>
<li>[General_Info; fine-grain-priority=100] Check B12 levels every 2 years as pt has Rx for metformin.</li><li>[General_Info; fine-grain-priority=100] As GFR  ?value (?date). would recheck q3-4 months.</li></ul>
<li><b>Msg start Insulin <font color=FF0000>preferred</font></b>(rule in criterion<i> true</i> evaluate to <b> true</b> )])
<ul>
<li>[General_Info; fine-grain-priority=100] If pt has severe hyperglycemia or excessive symptoms, consider starting insulin.</li></ul>
<li><b>Set target HbA1c 2017 <font color=FF0000>preferred</font></b>(rule in criterion<i> Absence Target HBA1c</i> evaluate to <b> true</b> )])
<ul>
<li>[General_Info; fine-grain-priority=300] Refer to  <a href="https://vaww.fre.cdw.va.gov/sites/D05_VISN21/Documents/CDS/VADoD_DM_CPG_2017.pdf#page=35"> Table 2 from VA 2017 DM Guidelines </a> to determine HbA1c target.</li></ul>
<li><b>Shared Decision Making Action <font color=FF0000>preferred</font></b>(rule in criterion<i> true</i> evaluate to <b> true</b> )])
<ul>
<li>[General_Info; fine-grain-priority=300] Strongly recommend shared decision making process, where pt, family and provider agree to plan of care and treatment. Info available <a href="https://vaww.fre.cdw.va.gov/sites/D05_VISN21/Documents/CDS/VADoD_DM_CPG_2017.pdf#page=23"> here</a>.</li></ul>
<li><b>TLC <font color=FF0000>preferred</font></b>(rule in criterion<i> true</i> evaluate to <b> true</b> )])
<ul>
<li>[General_Info; fine-grain-priority=300] Lifestyle changes to control DM.  Info available <a href="https://vaww.fre.cdw.va.gov/sites/D05_VISN21/Documents/CDS/VADoD_DM_CPG_2017.pdf#page=37"> here</a>.</li></ul>
</ul>
<li><b>dTwo drug choices II</b><br>
<ul>
<li><b>Make rec's <font color=FF0000>preferred</font></b>(strict rule-in condition<i> not at goal and not bad TZD and gemfibrozil</i> evaluate to <b> true</b> because <i>HbA1c(10.0:06/11/2013) && NOT (Pres gemfibrozil and TZD and not TZD contra)</i>)])
</ul>
<li><b>Can Intensify or Sub</b><br>
<ul>
<li><b>dIntensify II <font color=FF0000>preferred</font></b>(strict rule-in condition<i> true</i> evaluate to <b> true</b> )])
</ul>
<li><b>dIntensify choices II</b><br>
<ul>
<li><b>dCannot Increase dose <font color=FF0000>preferred</font></b>(strict rule-in condition<i> drug at max dose and not contraindicated</i> evaluate to <b> true</b> because <i>drug at max dose && NOT contraindication to non insulin agent</i>)])
</ul>
<li><b>dCannot Increase dose choices</b><br>
<ul>
<li><b>Rec 1st and 2nd line <font color=FF0000>preferred</font></b>(strict rule-in condition<i> 1 or 2 DM ecoded meds</i> evaluate to <b> true</b> because <i>not 3+ encoded DM medsEncoded DM Drugs(1) && Encoded DM Drugs(1)</i>)])
<ul>
<li>Evaluate_Start_Activity Evaluate start 1st and and 2nd line  fine-grain priority: 0</li><li>Evaluate_Start_Activity Initiate empa  fine-grain priority: 200</li></ul>
</ul>
<li><b>No meds, No recs</b><br>
<ul>
<li><b>Msg F/U <font color=FF0000>preferred</font></b>(strict rule-in condition<i> Presence of non-insulin agent rec add or blocked</i> evaluate to <b> true</b> )])
<ul>
<li>[Follow_Up; fine-grain-priority=100] Follow up in 3 months.</li></ul>
</ul>
</ul>
<b>Considerations for adding drug: </b><ul>
<li>Glipizide
<ul>
<li>specific drug(s): Glipizide</li>
<li>Is second-line drug for:  Diabetes Type 2(DM-Type2) 
<li>Recommendation basis: is second-line drug for
<li>preference: preferred
<li>fine-grained priority: 0
</ul>
<li>Saxagliptin
<ul>
<li>Is second-line drug for:  Diabetes Type 2(DM-Type2) 
<li>Recommendation basis: is second-line drug for
<li>preference: preferred
<li>fine-grained priority: 0
<ul>
<li>[General_Info; fine-grain-priority=100] Adjust saxagliptin for renal impairment or with CYP3A4/5 inhibitor.</li></ul>
</ul>
<li>Biguanide
<ul>
<li>specific drug(s): Metformin</li>
<li><font color=FF0000>Is first-line drug for:  Diabetes Type 2(DM-Type2) </font>
<li>Relative contraindications:  Presence of Metformin and 45<=eGFR<60 in past year([eGFR(55.0:06/11/2013) && eGFR(55.0:06/11/2013)]) 
<li>Already being used
<li>preference: ruled out
<li>fine-grained priority: 0
</ul>
<li>Thiazolidinediones
<ul>
<li>specific drug(s): Pioglitazone</li>
<li>Is second-line drug for:  Diabetes Type 2(DM-Type2) 
<li>Contraindications:  ADR anaphylaxis to TZD([Adverse_Reaction(Anaphylaxis)]) 
<li>Adverse reaction: Pioglitazone(Anaphylaxis)
<li>preference: ruled out
<li>fine-grained priority: 0
</ul>
</ul>
<b>Considerations for adding drug: </b><ul>
<li>Empagliflozin
<ul>
<li>Is second-line drug for:  Diabetes Type 2(DM-Type2) 
<li>Relative indications:  CVD DM(CVD_DM) 
<li>Recommendation basis: is second-line drug for
<li>preference: preferred
<li>fine-grained priority: 200
</ul>
</ul>
null<h2>Session time: 2013-07-3</h2>
<h2>GuidelineID: ATHENA DM:  Glycemic Control Dashboard</h2>
<h4>System Conclusions</h4>
<pre>
Conclusion: ATHENA DM:  Glycemic Control Dashboard Value: true
Case is eligible
</pre>
<p>
<b>Guideline Goal: HbA1c <= 9%</b>
(Presence of HbA1c)<p><b>Reached goal?</b> failed(HbA1c(10.0:06/11/2013))
<h4>Recommended Actions</h4>
<pre>
 <b>Message: On Metformin check serum B12 level</b>
 Message Type: General_Info
 Fine-grain priority: 100
 Message: Check B12 levels every 2 years as pt has Rx for metformin.
 <b>Message: On MF monitor GFR 45<=GFG<60</b>
 Message Type: General_Info
 Fine-grain priority: 100
 Message: As GFR  ?value (?date). would recheck q3-4 months.
 <b>Message: Msg Start insulin</b>
 Message Type: General_Info
 Fine-grain priority: 100
 Message: If pt has severe hyperglycemia or excessive symptoms, consider starting insulin.
 <b>Message: Set target HbA1c 2017</b>
 Message Type: General_Info
 Fine-grain priority: 300
 Message: Refer to  <a href="https://vaww.fre.cdw.va.gov/sites/D05_VISN21/Documents/CDS/VADoD_DM_CPG_2017.pdf#page=35"> Table 2 from VA 2017 DM Guidelines </a> to determine HbA1c target.
 <b>Message: Shared Decision Making Msg</b>
 Message Type: General_Info
 Fine-grain priority: 300
 Message: Strongly recommend shared decision making process, where pt, family and provider agree to plan of care and treatment. Info available <a href="https://vaww.fre.cdw.va.gov/sites/D05_VISN21/Documents/CDS/VADoD_DM_CPG_2017.pdf#page=23"> here</a>.
 <b>Message: TLC</b>
 Message Type: General_Info
 Fine-grain priority: 300
 Message: Lifestyle changes to control DM.  Info available <a href="https://vaww.fre.cdw.va.gov/sites/D05_VISN21/Documents/CDS/VADoD_DM_CPG_2017.pdf#page=37"> here</a>.
 <b>Evaluate_Start_Activity: Evaluate start 1st and and 2nd line</b>
 <b>Evaluate_Start_Activity: Initiate empa</b>
 <b>Message: Follow up in 3 months if less than 3 drugs</b>
 Message Type: Follow_Up
 Fine-grain priority: 100
 Message: Follow up in 3 months.
</pre>
<h4>Therapeutic Choices</h4>
<pre>

<b>add: </b>Glipizide
<b>Preference: </b>preferred
<b>Fine-grain priority: </b>0
<b>is_second_line_drug_for</b>: Diabetes Type 2

<b>add: </b>Saxagliptin
<b>Preference: </b>preferred
<b>Fine-grain priority: </b>0
<b>is_second_line_drug_for</b>: Diabetes Type 2
<b>Collateral Actions: </b>
      <b>Message: Sax dose adjustment</b>
      Message Type: General_Info
      Fine-grain priority: 100
      Message: Adjust saxagliptin for renal impairment or with CYP3A4/5 inhibitor.

<b>add: </b>Empagliflozin
<b>Preference: </b>preferred
<b>Fine-grain priority: </b>200
<b>relative_indication</b>: CVD DM
<b>is_second_line_drug_for</b>: Diabetes Type 2
</pre>
<br><br></body></html>
